Skip to main content
RT @Lupusreference: Today is RARE DISEASE DAY
Retweet 🔄 to raise awareness
of rare #autoimmune diseases
such as #Lupu

Laurent ARNAUD Lupusreference

4 years 6 months ago
Today is RARE DISEASE DAY Retweet 🔄 to raise awareness of rare #autoimmune diseases such as #Lupus https://t.co/EfjOfvNh1h
Drug Safety Advisories from regulators appears to reduce physician prescribing by 5.8%. Data from a study of 2 dozen adv

Dr. John Cush RheumNow

4 years 6 months ago
Drug Safety Advisories from regulators appears to reduce physician prescribing by 5.8%. Data from a study of 2 dozen advisories in 4 countries, Canada, Denmark, US, and UK between 2009 and 2015. https://t.co/TB6IeH9eGS https://t.co/2BiJJqQfSQ https://t.co/H3xuzyPJNX
Deaths due to non-benzodiazepine hypnotics and gabapentinoids increased significantly over the last two decades. Clinici

Dr. John Cush RheumNow

4 years 7 months ago
Deaths due to non-benzodiazepine hypnotics and gabapentinoids increased significantly over the last two decades. Clinicians should not assume that replacing benzodiazepines and opioids with these medications necessarily lowers risk to the patient. https://t.co/hfwKElpdFc https://t.co/lgHyRv7OyQ
Medicines 10 Lowest Hourly Wages
1 FP $89/hr
2. Int Med $90
3 ID $92
4 Peds $94
5 Endo $100
6 Rheum $102
7 Prevent $105

Dr. John Cush RheumNow

4 years 7 months ago
Medicines 10 Lowest Hourly Wages 1 FP $89/hr 2. Int Med $90 3 ID $92 4 Peds $94 5 Endo $100 6 Rheum $102 7 Prevent $105 8 Allergy $112 9 Neuro $114 10 Psych $117 https://t.co/EFTNYTUOgA https://t.co/wjcbC6dLML
The American College of Rheumatology and the American Association of Hip and Knee Surgeons released a summary of their updated guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
A recent prospective, randomized, blinded clinical trial has shown that a 2 week hold of methotrexate (MTX) following COVID-19 (Sinovac-CoronaVac) vaccination resulted in greater anti-SARS-CoV-2 immunogenicity; but there was an increase in flare rates after the second dose of vaccine.
Acute onset swelling in but a few joints. What's a hairdresser to do? What would you do?

QD Clinic is sponsored by http

Dr. John Cush RheumNow

4 years 7 months ago
Acute onset swelling in but a few joints. What's a hairdresser to do? What would you do? QD Clinic is sponsored by https://t.co/4UQlqwujiR (March 19 & 20, 2022 in Las Colinas, Texas) https://t.co/KYI05R1h5J https://t.co/GobpZ4TRhQ
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow. This week, rheumatologic problems inc

Dr. John Cush RheumNow

4 years 7 months ago
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow. This week, rheumatologic problems incited by respiratory infections, air pollution and how you live, now where you live. Download wherever you get your podcasts. https://t.co/AR08F92XSY https://t.co/sqqlHvSHUL
ICYMI: Prevent NSAID GI bleeding or perforation? Korean study (n=92K) shows (vs non-prophylaxis) PPI and COX-2 inhibitor

Dr. John Cush RheumNow

4 years 7 months ago
ICYMI: Prevent NSAID GI bleeding or perforation? Korean study (n=92K) shows (vs non-prophylaxis) PPI and COX-2 inhibitors associated with 64% and 74% reduced risk. COX2 = PPI +nsNSAID. H2-receptor antag. did not reduce the risk https://t.co/pUuVzwiQgx https://t.co/JAUqW9AMck
ICYMI: 144 SLE pts from the SLICC cohort were studied showing that a majority (61.2%) scores consistent with depression

Dr. John Cush RheumNow

4 years 7 months ago
ICYMI: 144 SLE pts from the SLICC cohort were studied showing that a majority (61.2%) scores consistent with depression over 4 yrs; also an inconsistent association between disease activity and depression in multivariate analysis https://t.co/YqxPFtYohf
ICYMI: Case showing flare of Dermatomyositis in a Patient With Psoriasis treated with Secukinumab. https://t.co/GvyXzcSN

Dr. John Cush RheumNow

4 years 7 months ago
ICYMI: Case showing flare of Dermatomyositis in a Patient With Psoriasis treated with Secukinumab. https://t.co/GvyXzcSNUa https://t.co/T83m5YojcH
×